Nanoparticles for ocular drug delivery: modified and non-modified chitosan as a promising biocompatible carrier

Nanomedicine (Lond). 2019 Jul;14(14):1889-1909. doi: 10.2217/nnm-2019-0040. Epub 2019 Jul 5.

Abstract

The eye is a very important, yet sensitive organ, presenting complex anatomy. To overcome its protective mechanisms, with the aim of improving drug delivery, drug encapsulation in nanocarriers is considered in this review. Chitosan is found to be an excellent drug carrier and its application in ophthalmology is being extensively researched. This mucoadhesive biopolymer can protect the encapsulated molecule, optimize its mode of action and minimize any existent risk. Moreover, chitosan and its derivatives may provide advantageous properties to the system such as thermoresponsivity and pH dependency. Finally, dual systems of chitosan with other carriers, such as poly (lactic-co-glycolic acid) and alginate, are also mentioned in this review, as they may offer additional benefits such as higher permeation due to different interaction of each carrier with the corneal layers.

Keywords: combined nanocarriers; dual systems; modified chitosan nanoparticles; ophthalmic drug delivery; sustained release.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Administration, Ophthalmic
  • Animals
  • Chitosan / chemistry*
  • Delayed-Action Preparations / chemistry*
  • Drug Delivery Systems / methods
  • Eye / drug effects
  • Eye / metabolism
  • Eye Diseases / drug therapy
  • Eye Diseases / metabolism
  • Humans
  • Nanoparticles / chemistry*
  • Nanotechnology / methods
  • Pharmaceutical Preparations / administration & dosage*
  • Polylactic Acid-Polyglycolic Acid Copolymer / chemistry

Substances

  • Delayed-Action Preparations
  • Pharmaceutical Preparations
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Chitosan